Apellis Pharmaceuticals
APLS
$29.36
Share price
-9.89%
Change (1 day)
-63.56%
Change (1 year)
Categories
Apellis Pharmaceuticals (APLS) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : S$0.88 Billion
According to Apellis Pharmaceuticals's latest financial reports the company's total liabilities are S$0.88 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Apellis Pharmaceuticals - Total liabilities on balance sheet (from 2014 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | S$0.89 B | 13.71% |
| 2023-12-31 | S$0.78 B | -0.84% |
| 2022-12-31 | S$0.79 B | -14.3% |
| 2021-12-31 | S$0.92 B | -7.67% |
| 2020-12-31 | S$1.00 B | 108.96% |
| 2019-12-31 | S$0.47 B | 723.16% |
| 2018-12-31 | S$58.14 M | 30.99% |
| 2017-12-31 | S$44.38 M | 742.85% |
| 2016-12-31 | S$5.26 M | 16.35% |
| 2015-12-31 | S$4.52 M | 216.76% |
| 2014-12-31 | S$1.42 M | 66.62% |
| 2013-12-31 | S$0.85 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | S$41.64 M | -95.28% | 🇺🇸 USA |